Ran Blekhman
- Biological Psychiatry top 2%
- Molecular Biology top 1%
- Gut microbiota and health 44
- Epigenetics and DNA Methylation 7
- Genomics and Phylogenetic Studies 5
- Genomics and Chromatin Dynamics 5
- Metabolomics and Mass Spectrometry Studies 4
- Infectious Diseases top 1%
- Clostridium difficile and Clostridium perfringens research 12
- Physiology top 2%
- Diet and metabolism studies 14
- Gastroenterology top 2%
-
- Probiotics and Fermented Foods 10
- Co-authors
- Andrew G. ClarkJordana T. BellRuth E. LeyJulia K. GoodrichTimothy D. SpectorRob KnightWilliam Van TreurenMichelle Beaumont
- Partner nations
- United StatesCanadaCzechia
In The Last Decade
Ran Blekhman
65 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Biological Psychiatry 214
- Molecular Biology 4.8k
- Infectious Diseases 1.1k
- Physiology 1.2k
- Gastroenterology 249
Countries citing papers authored by Ran Blekhman
This map shows the geographic impact of Ran Blekhman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Blekhman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Blekhman more than expected).
Fields of papers citing papers by Ran Blekhman
This network shows the impact of papers produced by Ran Blekhman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Blekhman. The network helps show where Ran Blekhman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Blekhman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 47 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 12 | |
| 10 | 2022 | 94 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 16 | |
| 14 | 2020 | 19 | |
| 15 | 2019 | 100 | |
| 16 | 2019 | 46 | |
| 17 | 2019 | 134 | |
| 18 | 2018 | 23 | |
| 19 | 2017 | 18 | |
| 20 | 2016 | 35 |
About Ran Blekhman
Ran Blekhman is a scholar working on Molecular Biology, Infectious Diseases and Information Systems and Management, having authored 68 papers that have together received 6.5k indexed citations. Recurring topics across this work include Gut microbiota and health (44 papers), Diet and metabolism studies (14 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Probiotics and Fermented Foods (10 papers), Epigenetics and DNA Methylation (7 papers), Genomics and Phylogenetic Studies (5 papers), Genomics and Chromatin Dynamics (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). The work is most often cited by research in Biological Psychiatry (214 citations), Molecular Biology (4.8k citations) and Infectious Diseases (1.1k citations). Ran Blekhman has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include Andrew G. Clark, Jordana T. Bell, Ruth E. Ley, Julia K. Goodrich, Timothy D. Spector, Rob Knight, William Van Treuren, Michelle Beaumont, Omry Koren and Jillian L. Waters. Their work appears in journals such as eLife, PLoS Genetics, mSystems, Scientific Reports and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.